← Back to Search

Yoga Intervention Group for Breast Cancer

N/A
Waitlist Available
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from beginning to end of recruitment period, up to 6 months.
Awards & highlights

Study Summary

The purpose of this pilot study is to assess the feasibility of a remotely-delivered yoga intervention for breast cancer survivors.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from beginning to end of recruitment period, up to 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from beginning to end of recruitment period, up to 6 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence rate
Adverse events
Attrition rate
+2 more
Secondary outcome measures
Objectively-assessed cognitive function
Self-reported cognitive function
Self-reported exercise
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Yoga Intervention GroupExperimental Treatment1 Intervention
All participants will be assigned to the yoga intervention group (single arm).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga Intervention
2021
N/A
~240

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,625 Total Patients Enrolled
8 Trials studying Breast Cancer
3,254 Patients Enrolled for Breast Cancer
Linda Trinh, PhDStudy DirectorUniversity of Toronto, Faculty of Kinesiology and Physical Education
3 Previous Clinical Trials
168 Total Patients Enrolled
1 Trials studying Breast Cancer
21 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Plos OneJournal
Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework
Eldridge, Sandra M., Gillian A. Lancaster, Michael J. Campbell, Lehana Thabane, Sally Hopewell, Claire L. Coleman, and Christine M. Bond. 2016. “Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework”. Edited by Chiara Lazzeri. Plos One. Public Library of Science (PLoS). doi:10.1371/journal.pone.0150205.
Journal of Psychiatric ResearchJournal
The Role and Interpretation of Pilot Studies in Clinical Research
Leon, Andrew C., Lori L. Davis, and Helena C. Kraemer. 2011. “The Role and Interpretation of Pilot Studies in Clinical Research”. Journal of Psychiatric Research. Elsevier BV. doi:10.1016/j.jpsychires.2010.10.008.
The Lancet OncologyJournal
International Cognition and Cancer Task Force Recommendations to Harmonise Studies of Cognitive Function in Patients with Cancer
Wefel, Jeffrey S, Janette Vardy, Tim Ahles, and Sanne B Schagen. 2011. “International Cognition and Cancer Task Force Recommendations to Harmonise Studies of Cognitive Function in Patients with Cancer”. The Lancet Oncology. Elsevier BV. doi:10.1016/s1470-2045(10)70294-1.
Journal of Evaluation in Clinical PracticeJournal
Design and Analysis of Pilot Studies: Recommendations for Good Practice
Lancaster, Gillian A., Susanna Dodd, and Paula R. Williamson. 2004. “Design and Analysis of Pilot Studies: Recommendations for Good Practice”. Journal of Evaluation in Clinical Practice. Wiley. doi:10.1111/j..2002.384.doc.x.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top